Hanson Gifford

Hanson Gifford

Directeur Général chez Qlt Plug Delivery, Inc.

Health Technology
Finance
Electronic Technology

Profil

Hanson is a Partner of LSV.
He assists the LSV medical device team with deal sourcing, due diligence, and portfolio company management.
He has served in this role since November 2013.
Hanson is also a Managing Partner at The Foundry, LLC, a medical device company incubator and a preferred partner to LSV.
Since its inception in 1998, Hanson has led The Foundry in all of its activities.
These include the invention, identification and development of new technologies, the formation, financing, and staffing of over twenty new companies, and ongoing support of these new ventures as a board member.
Success stories include Evalve (acquired by Abbott), Concentric (acquired by Stryker), Ardian (acquired by Medtronic), Twelve (acquired by Medtronic).
At ForSight Labs, an Ophthalmology-focused incubator started by Hanson, Eugene de Juan, MD, and K.
Angela Macfarlane, successes include Transcend Medical (acquired by Alcon), Forsight Newco 2 (acquired by QLT), Forsight Vision 4 (acquired by Genentech/Roche), and Forsight Vision 5 (acquired by Allergan).
Prior to The Foundry, Hanson was Vice President of Research and Development at Heartport, Inc., which had a successful IPO in 1996.
From 1993-1998, he built and led a 62-person team at Heartport developing a wide variety of novel devices and procedures for minimally invasive cardiac surgery.
In 1992-1993, Hanson co-founded and served as Managing Director of Bavaria Medizin Technologie, GmbH in Oberpfaffenhofen, Germany.
In 1991, Hanson co-founded and served as President of Cardiovascular Therapeutic Technologies (acquired by Eli Lilly).
From 1985-1990, Hanson worked at Devices for Vascular Intervention (acquired by Eli Lilly) in various engineering, clinical research and marketing capacities.
Before joining DVI, Hanson worked in engineering roles at Oximetrix and General Dynamics.
Hanson is a Director of FIRE1, Contego, Reprieve Cardiovascular, Half Moon Medical, Tangible Science, Apreo Health, and Mavericks Endo.

Postes actifs de Hanson Gifford

SociétésPosteDébut
Fondateur 31/01/2011
Directeur Général -
Directeur/Membre du Conseil 23/02/2011
Directeur/Membre du Conseil -
Fondateur 01/01/1998
Directeur/Membre du Conseil -
Private Equity Investor 01/11/2013
Foundry SING1, Inc. Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Tous les postes actifs de Hanson Gifford

Anciens postes connus de Hanson Gifford

SociétésPosteFin
░░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Hanson Gifford

Formation de Hanson Gifford

Cornell University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Hanson Gifford

Relations

100 +

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
GENERAL DYNAMICS CORPORATION

Electronic Technology

Entreprise privées30

Finance

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Oximetrix, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Finance

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Foundry SING1, Inc.

Health Services

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Hanson Gifford
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT